A randomized study of autologous bone marrow–derived stem cells in pediatric cardiomyopathy
Authors:
- 5 January 2017
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 36 (8) , 837-844
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Variability of M-Mode Versus Two-Dimensional Echocardiography Measurements in Children With Dilated CardiomyopathyPediatric Cardiology, 2013
- Effects of Intracoronary CD34 + Stem Cell Transplantation in Nonischemic Dilated Cardiomyopathy PatientsCirculation Research, 2013
- Intracoronary bone marrow cell application for terminal heart failure in childrenCardiology in the Young, 2012
- A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow–Derived Progenitor Cell Infusion in Patients With Nonischemic Dilated CardiomyopathyCirculation: Heart Failure, 2009
- New-Onset Heart Failure Due to Heart Muscle Disease in ChildhoodCirculation, 2008
- Carvedilol for Children and Adolescents With Heart FailureJAMA, 2007
- Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial InfarctionNew England Journal of Medicine, 2006
- Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trialThe Lancet, 2004
- The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized TrialsJAMA, 2001
- Reduction in Sample Size for Studies of Remodeling in Heart Failure by the Use of Cardiovascular Magnetic ResonanceJournal of Cardiovascular Magnetic Resonance, 2000